260 related articles for article (PubMed ID: 24420737)
21. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
[No Abstract] [Full Text] [Related]
22. A Nomogram to Predict Lymph Node Positivity Following Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer.
Newton AD; Li J; Jeganathan AN; Mahmoud NN; Epstein AJ; Paulson EC
Dis Colon Rectum; 2016 Aug; 59(8):710-7. PubMed ID: 27384088
[TBL] [Abstract][Full Text] [Related]
23. [Analysis of clinical predictive factors of pathologic complete response after neoadjuvant chemoradiotherapy in rectal cancer].
Yu T; Cao XL; Wu GJ; Zhao G; Jia WW; Xiao G; Wang X
Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(16):1274-7. PubMed ID: 27122460
[TBL] [Abstract][Full Text] [Related]
24. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
[No Abstract] [Full Text] [Related]
25. Metastatic pattern and new primary tumours after neoadjuvant therapy and surgery in rectal cancer.
Frambach P; Pucciarelli S; Perin A; Zuin M; Toppan P; Maretto I; Urso EDL; Spolverato G
Colorectal Dis; 2018 Dec; 20(12):O326-O334. PubMed ID: 30230157
[TBL] [Abstract][Full Text] [Related]
26. Predictors of Pathologic Complete Response Following Neoadjuvant Chemoradiotherapy for Rectal Cancer.
Al-Sukhni E; Attwood K; Mattson DM; Gabriel E; Nurkin SJ
Ann Surg Oncol; 2016 Apr; 23(4):1177-86. PubMed ID: 26668083
[TBL] [Abstract][Full Text] [Related]
27. Pathological complete response may underestimate distant metastasis in locally advanced rectal cancer following neoadjuvant chemoradiotherapy and radical surgery: Incidence, metastatic pattern, and risk factors.
Sun Y; Wu X; Zhang Y; Lin H; Lu X; Huang Y; Chi P
Eur J Surg Oncol; 2019 Jul; 45(7):1225-1231. PubMed ID: 30879932
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of changes in serum carcinoembryonic antigen levels for preoperative chemoradiotherapy response in locally advanced rectal cancer.
Cheong C; Shin JS; Suh KW
World J Gastroenterol; 2020 Nov; 26(44):7022-7035. PubMed ID: 33311947
[TBL] [Abstract][Full Text] [Related]
29. Comparison of Different Nodal Staging in Patients With Locally Advanced Mid-low Rectal Cancer After Long-term Neoadjuvant Chemoradiation Therapy.
Petrucciani N; Carra MC; Martínez-Pérez A; Vitali GC; Landi F; Genova P; Memeo R; Brunetti F; Espin E; Ris F; De'angelis N;
Anticancer Res; 2019 Apr; 39(4):2113-2120. PubMed ID: 30952757
[TBL] [Abstract][Full Text] [Related]
30. The effect of adjuvant chemotherapy on survival and recurrence after curative rectal cancer surgery in patients who are histologically node negative after neoadjuvant chemoradiotherapy.
Baird DLH; Denost Q; Simillis C; Pellino G; Rasheed S; Kontovounisios C; Tekkis PP; Rullier E
Colorectal Dis; 2017 Nov; 19(11):980-986. PubMed ID: 28493401
[TBL] [Abstract][Full Text] [Related]
31. The effect of preoperative chemoradiotherapy on lymph nodes harvested in TME for rectal cancer.
Scabini S; Montecucco F; Nencioni A; Zoppoli G; Sartini M; Rimini E; Massobrio A; De Marini L; Poggi A; Boaretto R; Romairone E; Ballestrero A; Ferrando V
World J Surg Oncol; 2013 Nov; 11():292. PubMed ID: 24246069
[TBL] [Abstract][Full Text] [Related]
32. Stage-Dependent Frequency of Lymph Node Metastases in Patients With Rectal Carcinoma After Preoperative Chemoradiation: Results from the CAO/ARO/AIO-94 Trial and From a Comparative Prospective Evaluation With Extensive Pathological Workup.
Sprenger T; Rothe H; Conradi LC; Beissbarth T; Kauffels A; Kitz J; Homayounfar K; Wolff H; Ströbel P; Ghadimi M; Wittekind C; Sauer R; Rödel C; Liersch T
Dis Colon Rectum; 2016 May; 59(5):377-85. PubMed ID: 27050599
[TBL] [Abstract][Full Text] [Related]
33. Outcomes of persistent lymph node involvement after neoadjuvant therapy for stage III rectal cancer.
Dinaux AM; Leijssen L; Bordeianou LG; Kunitake H; Amri R; Berger DL
Surgery; 2018 Apr; 163(4):784-788. PubMed ID: 29277386
[TBL] [Abstract][Full Text] [Related]
34. Nodal Disease in Rectal Cancer Patients With Complete Tumor Response After Neoadjuvant Chemoradiation: Danger Below Calm Waters.
Baucom RB; Maguire LH; Kavalukas SL; Geiger TM; Ford MM; Muldoon RL; Hopkins MB; Hawkins AT
Dis Colon Rectum; 2017 Dec; 60(12):1260-1266. PubMed ID: 29112561
[TBL] [Abstract][Full Text] [Related]
35. Clinical factors of post-chemoradiotherapy as valuable indicators for pathological complete response in locally advanced rectal cancer.
Peng J; Lin J; Qiu M; Wu X; Lu Z; Chen G; Li L; Ding P; Gao Y; Zeng Z; Zhang H; Wan D; Pan Z
Clinics (Sao Paulo); 2016 Aug; 71(8):449-54. PubMed ID: 27626475
[TBL] [Abstract][Full Text] [Related]
36. Predictors of Pathologic Complete Response in Rectal Cancer Patients Undergoing Total Mesorectal Excision After Preoperative Chemoradiation.
Han YD; Kim WR; Park SW; Cho MS; Hur H; Min BS; Baik SH; Lee KY; Kim NK
Medicine (Baltimore); 2015 Nov; 94(45):e1971. PubMed ID: 26559272
[TBL] [Abstract][Full Text] [Related]
37. NEOADJUVANT THERAPY AND SURGERY FOR RECTAL CANCER. Comparative study between partial and complete pathological response.
Andrade VA; Coy CS; Leal RF; Fagundes JJ; Martinez CA; Ayrizono Mde L
Arq Gastroenterol; 2016; 53(3):163-8. PubMed ID: 27438421
[TBL] [Abstract][Full Text] [Related]
38. Pretreatment identification of patients likely to have pathologic complete response after neoadjuvant chemoradiotherapy for rectal cancer.
van der Sluis FJ; van Westreenen HL; van Etten B; van Leeuwen BL; de Bock GH
Int J Colorectal Dis; 2018 Feb; 33(2):149-157. PubMed ID: 29247263
[TBL] [Abstract][Full Text] [Related]
39. Association between pretreatment haemoglobin levels and morphometric characteristics of the tumour, response to neoadjuvant treatment and long-term outcomes in patients with locally advanced rectal cancers.
Khan AA; Klonizakis M; Shabaan A; Glynne-Jones R
Colorectal Dis; 2013; 15(10):1232-7. PubMed ID: 23710579
[TBL] [Abstract][Full Text] [Related]
40. Elevated CEA levels and low distance of the tumor from the anal verge are predictors of incomplete response to chemoradiation in patients with rectal cancer.
Restivo A; Zorcolo L; Cocco IM; Manunza R; Margiani C; Marongiu L; Casula G
Ann Surg Oncol; 2013 Mar; 20(3):864-71. PubMed ID: 23010737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
